ANEB
Price:
$1.46
Market Cap:
$37.86M
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.[Read more]
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
ANEB
According to Anebulo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -184.40%. This represents a change of 225.83% compared to the average of -56.59% of the last 4 quarters.
The mean historical ROE of Anebulo Pharmaceuticals, Inc. over the last ten years is -82.06%. The current -184.40% ROE has changed 124.71% with respect to the historical average. Over the past ten years (40 quarters), ANEB's ROE was at its highest in in the December 2020 quarter at 45.70%. The ROE was at its lowest in in the June 2021 quarter at -135.96%.
Average
-82.06%
Median
-110.67%
Minimum
-215.12%
Maximum
102.05%
Discovering the peaks and valleys of Anebulo Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.75%
Maximum Annual ROE = 102.05%
Minimum Annual Increase = -238.51%
Minimum Annual ROE = -215.12%
Year | ROE | Change |
---|---|---|
2024 | -215.12% | 94.39% |
2023 | -110.67% | 144.75% |
2022 | -45.22% | -68.01% |
2021 | -141.34% | -238.51% |
The current ROE of Anebulo Pharmaceuticals, Inc. (ANEB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-123.67%
5-year avg
-82.06%
10-year avg
-82.06%
Anebulo Pharmaceuticals, Inc.’s ROE is greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than AnaptysBio, Inc. (-287.94%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Aerovate Therapeutics, Inc. (-90.19%), less than Opthea Limited (360.15%), greater than AN2 Therapeutics, Inc. (-57.63%), less than PMV Pharmaceuticals, Inc. (0%), greater than Molecular Partners AG (-24.20%), greater than null (-39.16%),
Company | ROE | Market cap |
---|---|---|
-50.10% | $97.11M | |
-47.95% | $202.87M | |
-287.94% | $677.65M | |
-55.92% | $621.09M | |
-90.19% | $76.81M | |
360.15% | $486.27M | |
-57.63% | $39.99M | |
0% | $83.31M | |
-24.20% | $216.81M | |
-39.16% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anebulo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anebulo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Anebulo Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the highest ROE for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 3-year average ROE for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 5-year average ROE for Anebulo Pharmaceuticals, Inc. (ANEB)?
How does the current ROE for Anebulo Pharmaceuticals, Inc. (ANEB) compare to its historical average?